Compounds > bicalutamide

bicalutamide and Invasiveness, Neoplasm

bicalutamide has been researched along with Invasiveness, Neoplasm in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's2 (13.33)29.6817
2010's11 (73.33)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Bergman, AM; Cioni, B; de Boer, JP; de Jong, J; Griffioen, AW; Hofland, I; Hooijberg, E; Lubeck, Y; Melis, MHM; Muraro, MJ; Peters, D; Sanders, J; van Beijnum, JR; van Burgsteden, J; van der Poel, HG; Vivié, J; Zaalberg, A; Zwart, W1
Auricchio, F; Castoria, G; Di Donato, M; Giovannelli, P; Migliaccio, A1
Cao, Q; Gong, Y; Gu, J; He, Z; Nie, H; Zhu, L1
Chang, C; Fujimoto, N; Lee, SO; Li, L; Liang, L; Lin, TH; Niu, Y; Xu, D; Yeh, S; Yeh, SD1
Chang, C; Dang, Q; He, D; Li, L; Liang, L; Song, W; Xie, H; Yang, Z; Yeh, S1
Chuu, CP; Huo, C; Kao, YH1
Daniels, G; Deng, F; Du, X; Lee, P; Li, Y; Melamed, J; Monaco, ME; Ren, Q; Wang, J; Wang, LH; Wu, X; Yang, Y; Ye, F; Zhang, D; Zhang, V1
Chang, C; Li, L; Niu, Y; Tian, J; Wen, S; Yeh, S1
Daizumoto, K; Dondoo, TO; Fukawa, T; Fukumori, T; Kanayama, HO; Kohzuki, M; Kowada, M; Kusuhara, Y; Mori, H; Nakatsuji, H; Takahashi, M1
Figueiredo, ML; Zolochevska, O1
Harris, KW; Johnson, MR; Jukkola-Vuorinen, A; Kauppila, JH; Pressey, C; Sandholm, J; Selander, KS; Tuomela, J; Vaarala, M1
Agreda, F; Lopez, MA; Morote, J; Placer, J; Planas, J; Salvador, C; Trilla, E1
Lee, EC; Packman, K; Tenniswood, M; Zhan, P1
Campo, B; Colombo, P; Giunta, P; Mazzucchelli, R; Montironi, R; Parente, M; Patriarca, C; Petrella, D; Zucchini, N1
Channer, K; Cockshott, ID; Denis, L; Newling, D; Soloway, M; Tyrrell, CJ1

Trials

3 trial(s) available for bicalutamide and Invasiveness, Neoplasm

ArticleYear
Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.
    The Journal of biological chemistry, 2013, Jul-05, Volume: 288, Issue:27

    Topics: Androgen Receptor Antagonists; Androgens; Anilides; Animals; Benzamides; Cell Line, Tumor; Curcumin; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Smad3 Protein; Tosyl Compounds; Transforming Growth Factor beta1; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2013
Elevated E-cadherin and alpha/beta-catenin expression after androgen deprivation therapy in prostate adenocarcinoma.
    Pathology, research and practice, 2003, Volume: 199, Issue:10

    Topics: Adenocarcinoma; alpha Catenin; Androgen Antagonists; Anilides; Antineoplastic Agents; beta Catenin; Cadherins; Cytoskeletal Proteins; Humans; Immunoenzyme Techniques; Male; Neoplasm Invasiveness; Nitriles; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds; Trans-Activators; Treatment Outcome

2003
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group.
    European urology, 1998, Volume: 33, Issue:1

    Topics: Acid Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents; Dose-Response Relationship, Drug; Estradiol; Follicle Stimulating Hormone; Humans; Liver Function Tests; Luteinizing Hormone; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds

1998

Other Studies

12 other study(ies) available for bicalutamide and Invasiveness, Neoplasm

ArticleYear
Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion.
    Nature communications, 2020, 09-09, Volume: 11, Issue:1

    Topics: Aged; Androgen Antagonists; Anilides; Biopsy; Blood Buffy Coat; Case-Control Studies; Cell Line, Tumor; Cell Movement; Chemotherapy, Adjuvant; Coculture Techniques; Disease-Free Survival; Humans; Macrophages; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Nitriles; Progression-Free Survival; Prostate; Prostatectomy; Prostatic Neoplasms; Receptors, Androgen; Robotic Surgical Procedures; Signal Transduction; Single-Cell Analysis; THP-1 Cells; Tosyl Compounds; Triggering Receptor Expressed on Myeloid Cells-1

2020
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly.
    Scientific reports, 2019, 03-14, Volume: 9, Issue:1

    Topics: Androgens; Anilides; Cell Line, Tumor; Cell Movement; Female; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Humans; MCF-7 Cells; Multiprotein Complexes; Neoplasm Invasiveness; Nitriles; Phosphatidylinositol 3-Kinases; Receptors, Androgen; src-Family Kinases; Tosyl Compounds; Triple Negative Breast Neoplasms

2019
Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Acetylcholine; Androgen Antagonists; Androgens; Anilides; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mecamylamine; Metribolone; Neoplasm Invasiveness; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Receptors, Cholinergic; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Tosyl Compounds; Transcription, Genetic; Up-Regulation

2013
Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.
    Oncotarget, 2015, Jun-10, Volume: 6, Issue:16

    Topics: Anilides; Animals; Benzamides; Cell Line, Tumor; Heterografts; Humans; Male; MAP Kinase Signaling System; Mast Cells; Matrix Metalloproteinase 9; Mice; Neoplasm Invasiveness; Neoplastic Stem Cells; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Long Noncoding; Tosyl Compounds

2015
Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells.
    Cancer letters, 2015, Dec-01, Volume: 369, Issue:1

    Topics: Androgen Antagonists; Anilides; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Humans; Insulin-Like Growth Factor I; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds

2015
ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
    Oncotarget, 2015, Dec-29, Volume: 6, Issue:42

    Topics: Anilides; Animals; Antineoplastic Agents, Hormonal; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coenzyme A Ligases; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Neoplasm Invasiveness; Nitriles; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA Interference; Signal Transduction; Time Factors; Tosyl Compounds; Transfection; Up-Regulation; Xenograft Model Antitumor Assays

2015
ASC-J9(®), and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals.
    Cancer letters, 2016, 07-01, Volume: 376, Issue:2

    Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents, Hormonal; Benzamides; Cell Line, Tumor; Cell Movement; Curcumin; Enhancer of Zeste Homolog 2 Protein; Humans; Male; Mice, Nude; Neoplasm Invasiveness; Neoplastic Stem Cells; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Side-Population Cells; Signal Transduction; STAT3 Transcription Factor; Tosyl Compounds; Xenograft Model Antitumor Assays

2016
Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
    Anticancer research, 2017, Volume: 37, Issue:1

    Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents, Hormonal; Benzamides; Blood Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Drug Resistance, Neoplasm; Galectin 3; Galectins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Nitriles; Oligonucleotide Array Sequence Analysis; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Signal Transduction; Tosyl Compounds; Transcription, Genetic; Xenograft Model Antitumor Assays

2017
Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells.
    The Prostate, 2011, Mar-01, Volume: 71, Issue:4

    Topics: Anilides; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; G1 Phase; Humans; Male; Mice; Neoplasm Invasiveness; NF-kappa B; Nitriles; Osteoclasts; Prostatic Neoplasms; S Phase; Signal Transduction; Tosyl Compounds; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins

2011
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.
    Breast cancer research and treatment, 2012, Volume: 132, Issue:2

    Topics: Androgen Antagonists; Anilides; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Ligands; Neoplasm Invasiveness; NF-kappa B; Nitriles; Protein Isoforms; RNA Interference; RNA, Messenger; Signal Transduction; Testosterone; Toll-Like Receptor 9; Tosyl Compounds; Transfection

2012
Analysis of the lipid profile and atherogenic risk during androgen deprivation therapy in prostate cancer patients.
    Urologia internationalis, 2013, Volume: 90, Issue:1

    Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Atherosclerosis; Biomarkers; Cholesterol; Gonadotropin-Releasing Hormone; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Nitriles; Prospective Studies; Prostatic Neoplasms; Risk Factors; Time Factors; Tosyl Compounds; Treatment Outcome; Triglycerides

2013
Induction of invasive phenotype by Casodex in hormone-sensitive prostate cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2002, Volume: 83, Issue:1-5

    Topics: Anilides; Antineoplastic Agents; Cell Cycle; Cell Death; Culture Media, Serum-Free; DNA Fragmentation; Flow Cytometry; Humans; Kinetics; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Nitriles; Phenotype; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tosyl Compounds; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2002